14-day Premium Trial Subscription Sign Up For FreeGet Free

$3.90 (5.41%)

Volume: 250k

Closed: Dec 07, 2021

Hollow Logo Score: 1.706

Biocept Stock Forecast

$3.90 (5.41%)

Volume: 250k

Closed: Dec 07, 2021

Score Hollow Logo 1.706
Which way will BIOC go? Request
Tue, Dec 07, 2021 Buy Candidate Upgraded
Stop-loss: $3.75 (-3.88%)
Key Stats
Beta 0.8
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 50 and the stock is currently not being overbought or oversold

On Tuesday Biocept stock price gained impressive 5.41%
(Updated on Dec 07, 2021)

Buy candidate since 2021-12-07

The Biocept stock price gained 5.41% on the last trading day (Tuesday, 7th Dec 2021), rising from $3.70 to $3.90. During the day the stock fluctuated 6.91% from a day low at $3.73 to a day high of $3.99. The price has risen in 5 of the last 10 days and is up by 10.48% over the past 2 weeks. Volume fell on the last day by -32 thousand shares and in total, 250 thousand shares were bought and sold for approximately $975.32 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.07% during the next 3 months and, with a 90% probability hold a price between $3.31 and $3.96 at the end of this 3-month period.

Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Tuesday, November 30, 2021, and so far it has fallen -1.27%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. The Biocept stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.86 and $3.83. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss

Biocept finds support from accumulated volume at $3.89 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.26 between high and low, or 6.91%. For the last week the stock has had a daily average volatility of 7.36%.

Our recommended stop-loss: $3.75 (-3.88%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 5 days ago.)

Is Biocept stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 1.706

Predicted Opening Price for Biocept of Wednesday, December 8, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 8, 2021 Current price
$3.87 $3.90 (Overvalued)
Buy Candidate Upgraded

Remember To Visit Our YouTube Channel

Analyst Ratings

On Oct 09, 2021 "Brookline Capital Acquisition" gave "" rating for BIOC. The price target was set to $3.91+2.1%.

Volatility and Risk
Daily Average Volatility: 7.36 %
Overall Risk: Very High High Medium Low Very Low
7.36 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $3.91
Price: $3.90
Support: $3.89

BIOC Insider Trading Show all Trades



Last 100 transactions
Buy: 5 188 209 | Sell: 1 682 160 (Shares)
Date Action Amount Person Type
Sep 02, 2021 Buy 80 000 Nall Michael W. Performance-Based Employee Stock Option (right to buy)
Sep 02, 2021 Buy 100 000 Nall Michael W. Employee Stock Option (right to buy)
Aug 31, 2021 Buy 150 000 Dugan Michael C Employee Stock Option (right to buy)
Aug 31, 2021 Buy 35 000 Terry Michael J Employee Stock Option (right to buy)
Aug 31, 2021 Buy 100 000 Kennedy Timothy Employee Stock Option (right to buy)
Show all Insider Trades


Last 100 transactions
Buy: 5 188 209 | Sell: 1 682 160 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 4.13 5.90 %
4.03 3.38 %
3.97 1.82 %
Current price: 3.90
Support 3.77 -3.23 %
3.71 -4.79 %
3.61 -7.31 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 4.07 4.36 %
4.04 3.59 %
3.91 0.26 %
Current price 3.90
Support 3.89 -0.26%
3.87 -0.77%
3.79 -2.82%

Click to get the best stock tips daily for free!

About Biocept

Biocept Biocept, Inc., a cancer diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The company’s cancer assays provide an information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors. It offers assays for solid tumor indications, such as ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE